Repligen (RGEN) Tops Q1 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $126.57 -4.13%
Revenue Growth %: +10.7%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +10.7%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $194 million versus the consensus estimate of $192.05 million.
GUIDANCE:
Repligen sees FY2026 EPS of $1.97-$2.05, versus the consensus of $1.97.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- A. O. Smith CEO Stephen Shafer named chairman
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
